Results 51 to 60 of about 18,397 (209)
Assessing patient perspectives on enrollment in lymphoma clinical trials
Cancer, Volume 132, Issue 8, 15 April 2026.Abstract Background Clinical trials drive advances in lymphoma care, yet certain patient groups including socioeconomically disadvantaged, racial/ethnic groups, and women remain underrepresented. Given limited/inconsistent data regarding solutions to improve clinical trial enrollment of these groups, the authors performed a study to assess patient ...
Neha Akkad +14 more
wiley +1 more source
Revista Brasileira de Terapia Intensiva, 2008 JUSTIFICATIVA E OBJETIVOS: A hiperleucocitose (> 100 x 10(9)/L) em leucemia mielóide crônica não é uma apresentação comum e pode determinar manifestações clínicas de hiper-viscosidade.
Juliana Amâncio +6 more
doaj +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Molecular Oncology, Volume 20, Issue 4, Page 947-961, April 2026.Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Estudio comparativo de secuencias de ARN en muestras de médula ósea de leucemia obtenidas de modelos animales, pacientes en etapa temprana y pacientes bajo tratamiento [PDF]
La leucemia es una enfermedad con una alta ocurrencia en el Ecuador y en el mundo, ya que afecta a los diferentes tipos de células sanguíneas, impactando principalmente a los niños y adolescentes.
Suasnavas Chacón, Byron Alejandro
core +1 more source
Journal of the Academy, 2020 En el individuo existe factores biopsicosocial o dimensiones como el contexto escolar, familiar y anímico los cuales cambian de manera radical a causa de una enfermedad crónica como la leucemia, desencadenando daños colaterales en la familia y en el ...
Diana Carolina Pimiento Idiarte +3 more
doaj +1 more source
HemaSphere, Volume 10, Issue 4, April 2026.Abstract Neurotoxicity is a common and potentially life‐threatening complication after chimeric antigen receptor T‐cell therapy (CART) for pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). The only consistently demonstrated clinical risk factor for severe neurotoxicity in prior studies is high, preinfusion bone marrow disease burden (DB).
Caroline Diorio +18 more
wiley +1 more source
Aplicações da metodologia fish em citogenética de neoplasias. [PDF]
, 2015 TCC(graduação) - Universidade Federal de Santa Catarina. Centro de Ciências Biológicas. Biologia.As neoplasias surgem em conseqüência de mutações acumulativas no material genético (DNA) de células normais, as quais sofrem alterações progressivas até se ...
Foppa, Carolina Ester
core
eJHaem, Volume 7, Issue 2, April 2026.ABSTRACT Objectives Targeted therapies have markedly improved outcomes in chronic lymphocytic leukaemia (CLL), particularly among patients with TP53 alterations and unmutated IGHV. However, real‐world studies report persistent inequalities in access to optimal care.
Susana Esteves +7 more
wiley +1 more source
Epigenetic reprogramming in multiple myeloma—Challenges and opportunities
International Journal of Cancer, Volume 158, Issue 2, Page 423-432, 15 January 2026.Abstract In cancer, mutational processes act in concert with epigenetic reprogramming to endow malignant cells with hallmark properties that underpin tumorigenesis. Compared with the relatively rigid and slow processes of genetic evolution, the plastic nature of chromatin enables cells to adapt to a changing environment more rapidly.
Subhasree Kumar +2 more
wiley +1 more source